ACEA, a highly selective CB1R agonist, was reported to provide a neuroprotective effect for ischemic stroke, Parkinson's disease, Alzheimer's disease, and epilepsy [29, 41, 42, 44]. This evidence concerns the gene CNR1 and Alzheimer disease.